Nancy Vinh has over twenty years of experience managing early and late phase, international clinical trials for drugs, biologics, cell therapy and combination products across a wide range of therapeutic areas. Formerly she was Head of Clinical Operations at Portola Pharmaceuticals (Nasdaq; PTLA) where she was responsible for the development of clinical trial operations, strategy and trial execution for a number of therapeutics. Earlier she headed up Clinical Operations at Cellerant Therapeutics, and Nile Therapeutics and led registrational and label expansion trials execution at CV Therapeutics.